(Q37388858)

English

The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample

scientific article published on 25 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample (English)

1 reference

Europe PubMed Central

20 August 2017

Thomas McGlashan

6

object named as

Thomas H McGlashan

1 reference

Europe PubMed Central

20 August 2017

Larry J. Seidman

8

object named as

Larry J Seidman

1 reference

Europe PubMed Central

20 August 2017

Kristin S Cadenhead

4

object named as

Kristin S Cadenhead

1 reference

Europe PubMed Central

20 August 2017

3

object named as

Jean Addington

1 reference

Europe PubMed Central

20 August 2017

5

object named as

Tyrone D Cannon

1 reference

Europe PubMed Central

20 August 2017

Barbara A. Cornblatt

2

object named as

Barbara A Cornblatt

1 reference

Europe PubMed Central

20 August 2017

author name string

Elaine F Walker

1

1 reference

Europe PubMed Central

20 August 2017

Diana O Perkins

7

1 reference

Europe PubMed Central

20 August 2017

Ming T Tsuang

9

1 reference

Europe PubMed Central

20 August 2017

Scott W Woods

10

1 reference

Europe PubMed Central

20 August 2017

Robert Heinssen

11

1 reference

Europe PubMed Central

20 August 2017

language of work or name

0 references

publication date

25 August 2009

1 reference

Europe PubMed Central

20 August 2017

Schizophrenia Research

1 reference

Europe PubMed Central

20 August 2017

115

1 reference

Europe PubMed Central

20 August 2017

1

1 reference

Europe PubMed Central

20 August 2017

50-57

1 reference

Europe PubMed Central

20 August 2017

Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

6 September 2017

Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

6 September 2017

Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

6 September 2017

North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

6 September 2017

Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

6 September 2017

Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

6 September 2017

The schizophrenia prodrome: a developmentally informed review and update for psychopharmacologic treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

6 September 2017

Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

6 September 2017

Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

6 September 2017

Diagnosing schizophrenia in the initial prodromal phase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

6 September 2017

Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

14 September 2017

The prodromal phase of first-episode psychosis: past and current conceptualizations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

28 September 2017

Neurodevelopment and the transition from schizophrenia prodrome to schizophrenia: research imperatives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

2 September 2018

Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

2 September 2018

Effects of cognitive therapy on the longitudinal development of psychotic experiences in people at high risk of developing psychosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

2 September 2018

Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

2 September 2018

Antipsychotic drug treatment in the prodromal phase of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2762547

2 September 2018

Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19709859

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19709859

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.SCHRES.2009.07.023

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37388858&oldid=2173350634"